{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:57:40Z","timestamp":1762430260702,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1080\/14653240701656053","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T01:27:35Z","timestamp":1196731655000},"page":"785-794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter"],"prefix":"10.1016","volume":"9","author":[{"given":"V.","family":"Pican\u00e7o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Behrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.T.","family":"Covas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Seifried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/14653240701656053_bib0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1056\/NEJM199401063300108","article-title":"Hemophilia A","volume":"330","author":"Hoyer","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1080\/14653240701656053_bib0010","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I","article-title":"Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators","volume":"59","author":"Soucie","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1080\/14653240701656053_bib0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4613-0331-2_2","article-title":"Molecular etiology of factor VIII deficiency in hemophilia A","volume":"386","author":"Antonarakis","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1080\/14653240701656053_bib0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2796.1997.130135000.x","article-title":"Haemophilia prophylaxis in young patients: a long-term follow-up","volume":"241","author":"Lofqvist","year":"1997","journal-title":"J Intern Med"},{"key":"10.1080\/14653240701656053_bib0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-2000-9819","article-title":"Correlation between factor VIII genotype and inhibitor development in hemophilia A","volume":"26","author":"Fakharzadeh","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1080\/14653240701656053_bib0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.moh.0000239700.94555.b1","article-title":"Gene therapy for hemophilia","volume":"13","author":"Ponder","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.1080\/14653240701656053_bib0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1538-7836.2007.02410.x","article-title":"Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment","volume":"5","author":"Pierce","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1080\/14653240701656053_bib0040","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/317726a0","article-title":"Distribution of factor VIII mRNA and antigen in human liver and other tissues","volume":"317","author":"Wion","year":"1985","journal-title":"Nature"},{"key":"10.1080\/14653240701656053_bib0045","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2003-02-0495","article-title":"Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy","volume":"102","author":"Grimm","year":"2003","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1080\/14653240701656053_bib0050","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1002\/jgm.494","article-title":"Surface-engineering of lentiviral vectors","volume":"6","author":"Verhoeyen","year":"2004","journal-title":"J Gene Med"},{"key":"10.1080\/14653240701656053_bib0055","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1006\/mthe.2000.0075","article-title":"Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro","volume":"1","author":"Miao","year":"2000","journal-title":"Mol Ther"},{"key":"10.1080\/14653240701656053_bib0060","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1089\/10430340260201671","article-title":"The canine factor VIII 3\u2032-untranslated region and a concatemeric hepatocyte nuclear factor 1 regulatory element enhance factor VIII transgene expression in vivo","volume":"13","author":"Notley","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1080\/14653240701656053_bib0065","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1080\/14653240701656053_bib0070","doi-asserted-by":"crossref","first-page":"17684","DOI":"10.1073\/pnas.0606197103","article-title":"Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo","volume":"21","author":"Philippe","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/14653240701656053_bib0075","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/jgm.591","article-title":"Hepatocyte-specific gene expression from integrated lentiviral vectors","volume":"6","author":"Nash","year":"2004","journal-title":"J Gene Med"},{"key":"10.1080\/14653240701656053_bib0080","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1634\/stemcells.2003-0106","article-title":"Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells","volume":"24","author":"Van Damme","year":"2006","journal-title":"Stem Cells"},{"key":"10.1080\/14653240701656053_bib0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1525-0016(03)00073-X","article-title":"Efficient production of human FVIII in hemophilic mice using lentiviral vectors","volume":"7","author":"Kootstra","year":"2003","journal-title":"Mol Ther"},{"key":"10.1080\/14653240701656053_bib0090","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2005-08-024976","article-title":"Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity","volume":"108","author":"Modlich","year":"2006","journal-title":"Blood"},{"key":"10.1080\/14653240701656053_bib0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hum.2006.17.253","article-title":"Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors","volume":"17","author":"Baum","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1080\/14653240701656053_bib0100","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1099\/0022-1317-68-9-2359","article-title":"Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH","volume":"68","author":"Mastromarino","year":"1987","journal-title":"J Gen Virol"},{"key":"10.1080\/14653240701656053_bib0105","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI116797","article-title":"Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium","volume":"92","author":"Molmenti","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1080\/14653240701656053_bib0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1089\/hum.1996.7.5-637","article-title":"Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo","volume":"7","author":"Okuyama","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1080\/14653240701656053_bib0115","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1128\/JVI.72.10.8150-8157.1998","article-title":"Development of a self-inactivating lentivirus vector","volume":"72","author":"Miyoshi","year":"1998","journal-title":"J Virol"},{"key":"10.1080\/14653240701656053_bib0120","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1006\/mthe.2001.0325","article-title":"In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors","volume":"3","author":"Stein","year":"2001","journal-title":"Mol Ther"},{"key":"10.1080\/14653240701656053_bib0125","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1182\/blood-2003-09-3217","article-title":"Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice","volume":"103","author":"Follenzi","year":"2004","journal-title":"Blood"},{"key":"10.1080\/14653240701656053_bib0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.gt.3302473","article-title":"Newborn liver gene transfer by an HIV-2-based lentiviral vector","volume":"12","author":"Salani","year":"2005","journal-title":"Gene Ther"},{"key":"10.1080\/14653240701656053_bib0135","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/15258160260194848","article-title":"Generation and characterization of human hematopoietic cell lines expressing factor VIII","volume":"11","author":"Tonn","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1080\/14653240701656053_bib0140","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1161\/01.ATV.0000100403.78731.9F","article-title":"Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cells","volume":"23","author":"Herder","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1080\/14653240701656053_bib0145","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0076-6879(02)46071-5","article-title":"Generation of HIV-1 derived lentiviral vectors","volume":"346","author":"Follenzi","year":"2002","journal-title":"Methods Enzymol"},{"key":"10.1080\/14653240701656053_bib0150","first-page":"259","article-title":"HIV-based vectors. Preparation and use","volume":"69","author":"Follenzi","year":"2002","journal-title":"Methods Mol Med"},{"key":"10.1080\/14653240701656053_bib0155","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/MCB.16.5.1936","article-title":"Role of the liver-enriched transcription factor hepatocyte nuclear factor 1In transcriptional regulation of the factor V111 gene","volume":"16","author":"McGlynn","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1080\/14653240701656053_bib0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/bst0300093","article-title":"Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin","volume":"30","author":"Kalsheker","year":"2002","journal-title":"Biochem Soc Trans"},{"key":"10.1080\/14653240701656053_bib0165","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1101\/gad.5.6.1042","article-title":"HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro","volume":"5","author":"Mendel","year":"1991","journal-title":"Genes Dev"},{"key":"10.1080\/14653240701656053_bib0170","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nbt0997-871","article-title":"Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo","volume":"15","author":"Zufferey","year":"1997","journal-title":"Nat Biotechnol"},{"key":"10.1080\/14653240701656053_bib0175","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1074\/jbc.270.8.3648","article-title":"The role of cleavage of the light chain at positions Arg1689 or Arg1721In subunit interaction and activation of human blood coagulation factor VIII","volume":"270","author":"Donath","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1080\/14653240701656053_bib0180","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1182\/blood.V100.13.4391","article-title":"Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD\/SCID mice. Nonobese diabetic\/severe combined immunodeficient","volume":"100","author":"Piacibello","year":"2002","journal-title":"Blood"},{"key":"10.1080\/14653240701656053_bib0185","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1073\/pnas.82.3.795","article-title":"Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages","volume":"82","author":"Perlmutter","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/14653240701656053_bib0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1517\/14728214.6.2.187","article-title":"Prospects and problems of gene therapy: an update","volume":"6","author":"Gorecki","year":"2001","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1080\/14653240701656053_bib0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/76095","article-title":"Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences","volume":"25","author":"Follenzi","year":"2000","journal-title":"Nat Genet"},{"key":"10.1080\/14653240701656053_bib0200","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2002-07-2211","article-title":"The degree of phenotypic correction of murine beta-thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number","volume":"101","author":"Persons","year":"2003","journal-title":"Blood"},{"key":"10.1080\/14653240701656053_bib0205","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ymthe.2004.02.017","article-title":"Limited lentiviral transgene expression with increasing copy number in an MGMT selection model: lack of copy number selection by drug treatment","volume":"9","author":"Zielske","year":"2004","journal-title":"Mol Ther"},{"key":"10.1080\/14653240701656053_bib0210","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/blood-2003-03-0677","article-title":"Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells","volume":"102","author":"Persons","year":"2003","journal-title":"Blood"},{"key":"10.1080\/14653240701656053_bib0215","doi-asserted-by":"crossref","first-page":"19587","DOI":"10.1074\/jbc.274.28.19587","article-title":"Expression of factor VIII by murine liver sinusoidal endothelial cells","volume":"274","author":"Do","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1080\/14653240701656053_bib0220","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1055\/s-0037-1616143","article-title":"Tissue distribution of factor VIII gene expression in vivo: a closer look","volume":"86","author":"Hollestelle","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1080\/14653240701656053_bib0225","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0038-1660099","article-title":"Increased factor VIII complex in fulminant hepatic failure","volume":"54","author":"Langley","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1080\/14653240701656053_bib0230","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V100.1.143","article-title":"Factor VIII expression in azoxymethane-induced murine fulminant hepatic failure","volume":"100","author":"Doering","year":"2002","journal-title":"Blood"},{"key":"10.1080\/14653240701656053_bib0235","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1073\/pnas.89.1.89","article-title":"Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes","volume":"89","author":"Kay","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/14653240701656053_bib0240","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/hum.1992.3.6-641","article-title":"Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo","volume":"3","author":"Kay","year":"1992","journal-title":"Hum Gene Ther"},{"key":"10.1080\/14653240701656053_bib0245","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1073\/pnas.87.21.8437","article-title":"Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes","volume":"87","author":"Wilson","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1080\/14653240701656053_bib0250","first-page":"415","article-title":"Gene therapy for chronic granulomatous disease","volume":"8","author":"Stein","year":"2006","journal-title":"Curr Opin Mol Ther"},{"key":"10.1080\/14653240701656053_bib0255","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1038\/nature05219","article-title":"Gene therapy: X-SCID transgene leukaemogenicity","volume":"443","author":"Thrasher","year":"2006","journal-title":"Nature"},{"key":"10.1080\/14653240701656053_bib0260","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm1393","article-title":"Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1","volume":"12","author":"Ott","year":"2006","journal-title":"Nat Med"},{"key":"10.1080\/14653240701656053_bib0265","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood-2004-11-4535","article-title":"Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis","volume":"105","author":"Modlich","year":"2005","journal-title":"Blood"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324907701470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324907701470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:11:19Z","timestamp":1761430279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324907701470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007]]}},"alternative-id":["S1465324907701470"],"URL":"https:\/\/doi.org\/10.1080\/14653240701656053","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2007]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/14653240701656053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}